Medical technology giant to invest €160m for creation of 600 jobs at Limerick city plant

Medical technology giant to invest €160m for creation of 600 jobs at Limerick city plant

A GLOBAL leader in medical technology innovations has announced that it is to pump more than €160m into the construction of a medical technology plant in Limerick city. 

Edwards Lifesciences Corporation, which produces patient-focused technology for structural heart disease and critical care monitoring, is headquartered in California and is projecting the creation of around 600 jobs once the facility is opened in 2021. 

Taoiseach Leo Varadkar will formally break ground at the new facility in the National Technology Park this Friday afternoon. 

The company had originally projected an €80m spend on the medical technology plant in October 2018. 

Taoiseach Leo Varadkar said the development of the Limerick city region is a major part of the Government’s Project Ireland 2040 plan. 

“We are planning for the city to grow by 50 percent over the next two decades through enhanced regional accessibility, improved international connectivity and a competitive, educated workforce. The fact that Edwards Lifesciences has chosen Limerick for this new permanent facility is a very positive endorsement of the region as a great place in which to live, work and invest.

“Lifesaving, cutting-edge technologies will be produced here, resulting in the creation of 600 highly skilled jobs. I wish the company and their new workforce the very best as they embark on this exciting new project,” Taoiseach Varadkar said. 

Edwards established operations in Ireland in 2018, and employs 50 people at a facility in the Shannon Freezone. The additional investment around its new facility includes the purchase of additional land, the construction of a larger facility to allow for possible future expansion and the integration of upgraded technology.

Michael Mussallem, Edwards’ chairman and CEO said: “We are proud to break ground today on a modern, state-of-the-art facility in Ireland that will serve as an important addition to our global supply chain to enable global delivery of our high-quality, life-saving heart valve therapies.

“Since we established operations in Ireland last year, we have appreciation for the excellent business environment to help develop our operations.  We are also proud that we have had the opportunity to begin to engage in local community activities and initiate educational and professional opportunities for our employees.  We are confident that the addition of our talented and experienced team in Ireland to our growing workforce in the U.S. and around the world will provide valuable support to our shared goal of serving more patients in need.”

Buy the e-paper of the Donegal Democrat, Donegal People's Press, Donegal Post and Inish Times here for instant access to Donegal's premier news titles.

Keep up with the latest news from Donegal with our daily newsletter featuring the most important stories of the day delivered to your inbox every evening at 5pm.